This disclosure relates to implantable medical devices, particularly systems and methods for sensing external magnetic fields in implantable medical devices.
Implantable medical devices (IMDs) include devices such as implantable defibrillators, cardioverters, neurostimulators, and pacemakers. Since the early 1980s, thousands of patients prone to irregular and sometimes life threatening heart rhythms have had IMDs implanted in their bodies, typically in the upper chest area above their hearts. Certain of these devices detect onset of abnormal heart rhythms and automatically apply corrective electrical therapy, specifically one or more bursts of electric energy, to hearts. When the bursts of electric current are of sufficient amplitude and are properly synchronized with the cardiac signal, they restore normal heart function without human intervention, sparing patients considerable discomfort and often saving their lives.
With the increase in use of magnetic resonance imaging (MRI) as a diagnostic tool, patients with IMDs are exposed to strong magnetic fields on a more frequent basis.
Disclosed herein, among other things, is an apparatus for sensing magnetic fields. An apparatus embodiment includes a sensing circuit with at least one inductor having a magnetic core that saturates in the presence of a magnetic field having a prescribed flux density. The apparatus embodiment also includes an impedance measuring circuit connected to the sensing circuit. The impedance measuring circuit is adapted to measure impedance of the sensing circuit and to provide a signal when the impedance changes by a prescribed amount.
An apparatus embodiment includes means for sensing the presence of a magnetic field from a magnetic resonance imaging device. This apparatus embodiment also includes means for measuring impedance connected to the sensing means, including means for signaling when the measured impedance changes by a prescribed amount. The means for sensing includes a resistor-inductor-capacitor (RLC) circuit, according to various embodiments. According to an embodiment, the means for measuring includes a transthoracic impedance measurement module (TIMM).
One aspect of this disclosure relates to an implantable medical device with magnetic field sensing capability. The device embodiment includes a sensing circuit with at least one inductor having a magnetic core that saturates in the presence of a magnetic field having a prescribed flux density. The device embodiment also includes an impedance measuring circuit connected to the sensing circuit. The impedance measuring circuit is adapted to measure the impedance of the sensing circuit and to provide a signal when the impedance changes by a prescribed amount. The device embodiment further includes a controller adapted to receive the signal and modify device behavior while in the presence of the magnetic field.
One aspect of this disclosure relates to a method for sensing external magnetic fields. The method embodiment includes sensing a magnetic field using a circuit having an inductor with a magnetic core that saturates in the presence of a magnetic field having a prescribed flux density, measuring impedance of the circuit, and sending a signal to an implantable medical device when the measured impedance indicates the inductor is saturated.
This Summary is an overview of some of the teachings of the present application and is not intended to be an exclusive or exhaustive treatment of the present subject matter. Further details are found in the detailed description and appended claims. Other aspects will be apparent to persons skilled in the art upon reading and understanding the following detailed description and viewing the drawings that form a part thereof, each of which is not to be taken in a limiting sense. The scope of the present invention is defined by the appended claims and their legal equivalents.
The following detailed description refers to the accompanying drawings which show, by way of illustration, specific aspects and embodiments in which the present invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention. Other embodiments may be utilized and structural, logical, and electrical changes may be made without departing from the scope of the present invention.
According to various embodiments, the sensing circuit includes a resistor-inductor-capacitor (RLC) circuit. The impedance of the inductor changes upon saturation of the magnetic core, which changes the impedance of the RLC circuit containing the inductor. The impedance measuring circuit provides the signal to an implantable medical device, and the device modifies a behavior after receiving the signal, in various embodiments. Modifying device behavior may include changing to a pacing mode, changing to a tachy mode, changing lead configuration, or changing to a protect mode, according to various embodiments. Other types of device behavior or characteristics may be changed or modified upon receipt of the signal without departing from the scope of this disclosure.
According to an embodiment, the inductor or inductors include a ferrite drum core inductor. Other types of inductors can be used. Examples include, but are not limited to: gapped toroidal inductors or tape wound core inductors. According to various embodiments, the inductor or inductors include an isotropic material, so that the inductor(s) saturate as a result of magnetic field intensity only, independent of direction. According to various embodiments, the inductor is sized to fit within the housing of an implantable medical device. The inductor has maximum dimensions of 0.4 inches in width, 0.4 inches in length and 0.3 inches in height, according to one embodiment.
An apparatus embodiment includes means for sensing the presence of a magnetic field from a magnetic resonance imaging device. This apparatus embodiment also includes means for measuring impedance connected to the sensing means, including means for signaling when the measured impedance changes by a prescribed amount. The means for sensing includes a resistor-inductor-capacitor (RLC) circuit, according to various embodiments. According to an embodiment, the means for measuring includes a transthoracic impedance measurement module (TIMM). According to various embodiments, the means for sensing includes an inductor having a magnetic core that saturates at a selected magnetic flux density. The selected magnetic flux density includes a flux density of a Magnetic Resonance Imaging (MRI) machine, in an embodiment. The prescribed amount of impedance change includes a difference in impedance caused by saturation of the magnetic core, in various embodiments. The means for sensing includes an RLC circuit in an embodiment. Other types of sensing circuits having inductive elements capable of impedance changes at a prescribed flux density can be used. The means for measuring includes a TIMM in various embodiments. Other types of circuits able to measure impedance or detect a parameter indicative of impedance can be used without departing from the scope of this disclosure. According to various embodiments, detecting a parameter indicative of impedance includes detecting phase shift. The saturable magnetics described need not be a single inductor, but may include multiple inductors in a variety of orientations. The means for measuring can include a controller in various embodiments.
According to various embodiments, the impedance measuring circuit 104 includes a transthoracic impedance measurement module (TIMM). The TIMM includes at least one voltage source 240 and a first current source 244 and second current source 242. The two current sources depicted in the figure are not essential, and a single source can by used so long as the source can provide both positive and negative current pulses to the sensor circuit. According to various embodiments, the sensing circuit includes a resistor-inductor-capacitor (RLC) circuit. In the depicted embodiment, the resistor 224, the capacitor 222 and the inductor 220 are connected in parallel. Other types of circuits, including series RLC circuits, can be used without departing from the scope of this disclosure. A second resistor 226 is shown in series with the inductor 220.
As discussed in
As stated above, the inductor is selected with a magnetic core that saturates at a prescribed flux density. The flux density is chosen to cause saturation in the presence of a chosen magnetic field (such as that of an MRI device). Once this flux density is reached, the inductance, and therefore the impedance, of the sensor circuit drops dramatically. The measurement circuit measures the impedance of the sensing circuit at programmed intervals. According to various embodiments, impedance of the sensing circuit is measured at a frequency from 1 kHz to 1 MHz. According to one embodiment, a current pulse is generated at 2.0 Hz. The impedance of the sensing circuit is measured once every 30 seconds, in an embodiment.
According to various embodiments, the impedance measuring circuit includes a transthoracic impedance measurement module (TIMM). The sensing circuit includes a resistor-inductor-capacitor (RLC) circuit, according to various embodiments. In an embodiment, the sensing circuit includes multiple inductors oriented in more than one direction. The prescribed flux density includes flux density of a Magnetic Resonance Imaging (MRI) machine, according to one embodiment. According to various embodiments, the disclosed systems and methods can be used with a leadless device. For example, in an embodiment, one or more satellite electrodes are controlled wirelessly to deliver electrical therapy.
According to various embodiments, measuring impedance of the circuit includes measuring impedance of the circuit by providing a current pulse to the circuit and measuring voltage across the circuit. The impedance may also be measured by providing a known voltage across the circuit and measuring the current through the circuit. Other methods for measuring impedance of the circuit may be used without departing from the scope of this disclosure.
The present disclosure provides systems and methods for sensing external magnetic fields in implantable medical devices. The systems function as an omnidirectional MRI detection circuit capable of signaling the IMD to indicate the presence of a strong magnetic field. The described systems and methods have several advantages, including but not limited to: eliminating false charge timeouts that occur in devices when attempting to charge while magnetics are saturated; preventing induced currents from flowing in a lead system; and, as mentioned above, allowing an implantable device to modify its behavior when exposed to strong magnetic fields. The described systems and methods can be implemented as part of an implantable device, or separate from and in conjunction with the device. Types of devices that can benefit from the described systems and methods include, but are not limited to: cardiac resynchronization therapy (CRT) devices, defibrillators, pacemakers and neural stimulators.
One of ordinary skill in the art will understand that, the modules and other circuitry shown and described herein can be implemented using software, hardware, and combinations of software and hardware. As such, the illustrated modules and circuitry are intended to encompass software implementations, hardware implementations, and software and hardware implementations.
This application is intended to cover adaptations or variations of the present subject matter. It is to be understood that the above description is intended to be illustrative, and not restrictive. The scope of the present subject matter should be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled.
This application is a division of and claims the benefit of priority under 35 U.S.C. § 120 to U.S. patent application Ser. No. 15/662,091, filed on Jul. 27, 2017, which is a continuation of and claims the benefit of priority under 35 U.S.C. § 120 to U.S. patent application Ser. No. 14/204,559, filed on Mar. 11, 2014, now issued a U.S. Pat. No. 9,766,307, which is a continuation of and claims the benefit of priority under 35 U.S.C, § 120 to U.S. patent application Ser. No. 13/282,968, filed on Oct. 27, 2011, now issued as U.S. Pat. No. 8,710,826, which is a continuation of and claims the benefit of priority under 35 U.S.C. § 120 to U.S. patent application Ser. No. 11/460,081, filed on Jul. 26, 2006, now issued as U.S. Pat. No. 8,049,489, all of which are hereby incorporated by reference herein in their entirety.
Number | Date | Country | |
---|---|---|---|
Parent | 15662091 | Jul 2017 | US |
Child | 17143961 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14204559 | Mar 2014 | US |
Child | 15662091 | US | |
Parent | 13282968 | Oct 2011 | US |
Child | 14204559 | US | |
Parent | 11460081 | Jul 2006 | US |
Child | 13282968 | US |